Additional information
White Powder
265989-44-4
ACI-011225
208.2-209.0°C
C33H34FN2NaO6
596.62
Ambient
2-8°C
Cardiovascular
Pharmaceutical Impurity Standards
(ßR,dR)-2-(4-fluorophenyl)-ß,d-dihydroxy-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-Pyrrole-1-heptanoic acid sodium salt
(ßR,dR)-2-(4-fluorophenyl)-ß,d-dihydroxy-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-Pyrrole-1-heptanoic acid sodium salt
4-Hydroxy atorvastatin





![TOFACITINIB DIMER (25 mg) (1,3-Bis{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-1,3-propanedione)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)